The Development of an Asymmetric Hydrogenation Process for the Preparation of Solifenacin

Citations Over TimeTop 10% of 2012 papers

Abstract

The successful development of a catalytic imine asymmetric hydrogenation process for the reduction of the hydrochloride salt of 1-phenyl-3,4-dihydroisoquinoline to 1-(S)-phenyl-1,2,3,4-tetrahydroisoquinoline is described. This represents a novel approach to the key intermediate in preparing the urinary antispasmodic drug solifenacin, (1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate. Suitable reaction conditions were identified through an extensive screen of catalysts and combination of solvents and additives. The best reaction conditions: [Ir(COD)Cl]2-(S)-P-Phos, molar substrate to catalyst ratio (S/C) of >1000/1, THF, 1–2 equiv of H3PO4, 60 °C, 20 bar H2, were reproduced on a 200 g scale (95% isolated yield, 98% ee and >99% HPLC product purity).

Related Papers

• → Total Syntheses of Menisporphine and Daurioxoisoporphine C Enabled by Photoredox-Catalyzed Direct C–H Arylation of Isoquinoline with Aryldiazonium Salt(2014)87 cited
• → A review of the synthesis of 1,2-dihydroisoquinoline, [2,1-a] isoquinoline and [5,1-a] isoquinoline since 2006(2021)15 cited
• → Copper(I)-Catalyzed Formation of Isoquinoline and Quinoline Substituted Isobenzofurans(2022)14 cited
• → ChemInform Abstract: A Novel Route to Isoquinoline[2,1‐g][1,6]naphthyridine, Pyrazolo[5,1‐a]isoquinoline and Pyridazino[4′,5′:3,4]pyrazolo[5,1‐a]isoquinoline Derivatives with Evaluation of Antitumor Activities.(2013)
• Study on Synthesis of isoquinoline Derivatives(2008)